174 related articles for article (PubMed ID: 35267106)
1. Context-dependent activation of p53 target genes and induction of apoptosis by actinomycin D in aerodigestive tract cancers.
Adeluola AA; Bosomtwe N; Long TE; Amin ARMR
Apoptosis; 2022 Jun; 27(5-6):342-353. PubMed ID: 35267106
[TBL] [Abstract][Full Text] [Related]
2. Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells.
Kleeff J; Kornmann M; Sawhney H; Korc M
Int J Cancer; 2000 May; 86(3):399-407. PubMed ID: 10760829
[TBL] [Abstract][Full Text] [Related]
3. AKT mediates actinomycin D-induced p53 expression.
Chen CS; Ho DR; Chen FY; Chen CR; Ke YD; Su JG
Oncotarget; 2014 Feb; 5(3):693-703. PubMed ID: 24525337
[TBL] [Abstract][Full Text] [Related]
4. Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy.
Choong ML; Yang H; Lee MA; Lane DP
Cell Cycle; 2009 Sep; 8(17):2810-8. PubMed ID: 19657224
[TBL] [Abstract][Full Text] [Related]
5. NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.
Kiss A; Csikos C; Regdon Z; Polgár Z; Virág L; Hegedűs C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445574
[TBL] [Abstract][Full Text] [Related]
6. p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapy.
Rao B; Lain S; Thompson AM
Br J Cancer; 2013 Dec; 109(12):2954-8. PubMed ID: 24231949
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
Brodská B; Holoubek A; Otevřelová P; Kuželová K
J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
[TBL] [Abstract][Full Text] [Related]
8. Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer.
Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Qian Y; Zhang L; Ma H; Jiang X
Int J Nanomedicine; 2012; 7():1449-60. PubMed ID: 22619505
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
[TBL] [Abstract][Full Text] [Related]
10. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
[TBL] [Abstract][Full Text] [Related]
11. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.
Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H
Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161
[TBL] [Abstract][Full Text] [Related]
12. Actinomycin D synergistically enhances the cytotoxicity of CDDP on KB cells by activating P53 via decreasing P53-MDM2 complex.
Wang L; Pang XC; Yu ZR; Yang SQ; Liu AL; Wang JH; Du GH
J Asian Nat Prod Res; 2017 Jun; 19(6):630-643. PubMed ID: 28440085
[TBL] [Abstract][Full Text] [Related]
13. CD95-related apoptotic machinery is functional in pancreatic cancer cells.
Glazyrin AL; Adsay VN; Vaitkevicius VK; Sarkar FH
Pancreas; 2001 May; 22(4):357-65. PubMed ID: 11345135
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronidase induces murine L929 fibrosarcoma cells resistant to tumor necrosis factor and Fas cytotoxicity in the presence of actinomycin D.
Chang NS
Cell Biochem Biophys; 1995-1996; 27(2):109-32. PubMed ID: 9106395
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma.
Yamamoto T; Ohno T; Wakahara K; Nagano A; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Shimizu K
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1125-36. PubMed ID: 19205734
[TBL] [Abstract][Full Text] [Related]
16. Activation of p53 in cervical carcinoma cells by small molecules.
Hietanen S; Lain S; Krausz E; Blattner C; Lane DP
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8501-6. PubMed ID: 10900010
[TBL] [Abstract][Full Text] [Related]
17. Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes.
Kalousek I; Brodska B; Otevrelova P; Röselova P
Anticancer Drugs; 2007 Aug; 18(7):763-72. PubMed ID: 17581298
[TBL] [Abstract][Full Text] [Related]
18. G protein coupled receptor kinase 5 modifies the nucleolar stress response activated by actinomycin D.
Sok V; Jacinto AZ; Peng N; Eldemerdash M; Le L; Tran PD; Feng LF; Patel JR; Gi M; Ammon JC; So CH
Biochem Cell Biol; 2021 Aug; 99(4):508-518. PubMed ID: 33507833
[TBL] [Abstract][Full Text] [Related]
19. Force spectroscopy reveals the DNA structural dynamics that govern the slow binding of Actinomycin D.
Paramanathan T; Vladescu I; McCauley MJ; Rouzina I; Williams MC
Nucleic Acids Res; 2012 Jun; 40(11):4925-32. PubMed ID: 22328730
[TBL] [Abstract][Full Text] [Related]
20. Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces p53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4.
Guijarro LG; Sanmartin-Salinas P; Pérez-Cuevas E; Toledo-Lobo MV; Monserrat J; Zoullas S; Sáez MA; Álvarez-Mon MA; Bujan J; Noguerales-Fraguas F; Arilla-Ferreiro E; Álvarez-Mon M; Ortega MA
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
